Blockchain in Chemical Value Chains
Interview with Jens Schmidt, ReCarbonX
Innovation
Enabling the Best Possible Drug
Interview with Oliver Reimann and Andreas Regnery, Belyntic
Transforming the Scale-Up of Biobased Molecules
Interview with Jere Koskinen and Ali Harlin, Mega Cellulose.
Redesigning Tomorrow’s Plastics Today
B4Plastics is a Belgium-based biotechnology start-up and a polymer architecture company looking to catalyze the introduction of novel biomaterials and growing them from niche to bulk applications.
Artificial Intelligence for New Drug Design
Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.
Rethinking the Base Material Side
Plafco Fibertech, founded in 2017, was created as a spin-off from an EU-research project coordinated by Jukka Valkama, a professor at the Cooperative State University of Baden Wurttemberg in Karlsruhe, Germany.
Paving the Way for Sustainable Infection Control
LipoCoat is a biotech company specialized in ‘bio-inspired’ coatings that improve the safety, comfort, and performance of medical devices with a focus on health and nutrition.
Vaccine Filling at the Highest Level
Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been little involved in the production of vaccines. This is changing with the outbreak of the Covid-19 pandemic.
New Ammonia Synthesis Technology
Tsubame BHB was established in April of 2017 based on a new catalyst technology developed by Prof. em. Hideo Hosono at the Tokyo Institute of Technology (Tokyo Tech), which allows an ammonia process at lower temperature and pressure.
Chemistry is ... Safety through Freedom of Design
American football is a fascinating sport that is gaining more and more fans in Germany and elsewhere.
Excited About Coatings
Affix Labs over the past 5 years has specialized in binding technologies and commercialized first products in 2019.
A New Standard for Process Simulation — and Beyond
Hafnium Labs is tackling one of the toughest challenges in chemical R&D: Obtaining reliable physical property data — fast.
Accelerated Drug Discovery
In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.
Glucose Control of Bioprocesses
Online Monitoring and Control of Bioreactors by Mid-Infrared Spectroscopy
Revolutionizing Surface Functionalization
Single-step, Ambient, Dry Grafting of Organic Compounds and Biomolecules onto any Substrate.
Reshaping Adhesion - and the Industry
Hybrid assemblies, joints of dissimilar materials, are everywhere - in our smartphones, cars, TVs, dishwashers, in planes and so on. However, in modern products we increasingly rely on plastics, which are intrinsically hard to bond to other types of material — and by using industrial glue for the bonding the parts cannot be recycled easily. Solving this monumental challenge inspired the foundation of the Danish start-up company RadiSurf five years ago.
Creating the AI-Powered Future of Chemistry
Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.
Smart Tools for Chemical Research
Iris.ai was founded at Singularity University at NASA Ames Research Park in 2015. Challenged to come up with an idea that would positively impact the lives of 1 billion people, the team was formed and problem areas were explored.
Expert Webinar: Accelerating Drug Commercialization
New therapies to address unmet and emerging medical needs are being discovered at an explosive rate, building on rapid advances in molecular biology and genetics.
Experts Statements: Dr. Jörg Mohr, Saltigo
Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs.
